ZIPOLI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.957
EU - Europa 2.674
AS - Asia 1.704
SA - Sud America 176
OC - Oceania 47
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.601
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.915
RU - Federazione Russa 850
IT - Italia 631
SG - Singapore 441
CN - Cina 439
HK - Hong Kong 280
SE - Svezia 265
IE - Irlanda 232
VN - Vietnam 185
KR - Corea 152
BR - Brasile 140
PL - Polonia 137
UA - Ucraina 131
DE - Germania 122
FR - Francia 106
FI - Finlandia 85
TR - Turchia 56
GB - Regno Unito 52
IN - India 52
AU - Australia 47
CH - Svizzera 26
MX - Messico 18
AR - Argentina 17
BD - Bangladesh 16
CA - Canada 16
JP - Giappone 15
CI - Costa d'Avorio 11
CZ - Repubblica Ceca 10
IQ - Iraq 10
JO - Giordania 9
SC - Seychelles 9
NL - Olanda 8
ES - Italia 6
EC - Ecuador 5
MA - Marocco 5
PH - Filippine 5
TH - Thailandia 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
ID - Indonesia 4
IR - Iran 4
NP - Nepal 4
SA - Arabia Saudita 4
VE - Venezuela 4
AZ - Azerbaigian 3
CO - Colombia 3
EU - Europa 3
PK - Pakistan 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
BE - Belgio 2
CR - Costa Rica 2
CY - Cipro 2
EG - Egitto 2
IL - Israele 2
KE - Kenya 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
CL - Cile 1
CV - Capo Verde 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LY - Libia 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 9.601
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.102
Fairfield 487
Ashburn 369
Singapore 256
Chandler 247
Dublin 232
Woodbridge 232
Hong Kong 230
Jacksonville 213
Seattle 204
Cambridge 202
Houston 179
Wilmington 166
Seoul 146
Warsaw 137
Beijing 133
Buffalo 113
Milan 90
Altamura 84
San Jose 80
The Dalles 77
Lawrence 71
Ann Arbor 65
Princeton 65
Hefei 56
Lauterbourg 55
Ho Chi Minh City 51
Hanoi 47
Melbourne 47
Izmir 44
Boardman 43
Dearborn 43
Rome 43
Los Angeles 42
Medford 38
Boston 37
Dallas 33
Mumbai 33
Kent 31
Munich 29
Moscow 28
Paris 25
Bern 23
Shanghai 21
Florence 20
New York 20
Turin 18
Norwalk 17
Naples 16
San Diego 16
Orem 14
Council Bluffs 13
São Paulo 13
Abidjan 11
Helsinki 11
Bologna 10
Genoa 10
Haiphong 10
Tokyo 10
Verona 10
Andover 9
Tianjin 9
Turku 9
Brno 8
Chicago 8
Frankfurt Am Main 8
West Jordan 8
Auburn Hills 7
Da Nang 7
Guangzhou 7
L'aquila 7
Palermo 7
Washington 7
Yubileyny 7
Bari 6
Brasília 6
Hillsboro 6
London 6
Miano 6
Shenzhen 6
Brescia 5
Brooklyn 5
Cagliari 5
Falls Church 5
Frankfurt am Main 5
Johannesburg 5
Redondo Beach 5
Venice 5
Manchester 4
Montreal 4
Pescara 4
Saint Petersburg 4
San Francisco 4
Wŏnju 4
Zhengzhou 4
Baghdad 3
Baku 3
Bergamo 3
Buenos Aires 3
Bình Phước 3
Totale 6.395
Salva come PNG Salva come JPEG
Nome #
Associazione tra atrofia della sostanza grigia neocorticale e progressione del deficit cognitivo in pazienti con sclerosi multipla recidivante remittente 280
THE RAO'S BRIEF REPEATABLE BATTERY AND STROOP TEST: NORMATIVE VALUES WITH AGE, EDUCATION AND GENDER CORRECTIONS IN AN ITALIAN POPULATION. 244
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. 218
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 212
Cognitive impairment and event-related potentials in paediatric multiple sclerosis: 2-year study. 209
Cognitive impairment in early stages of multiple sclerosis. 209
BRAIN DAMAGE AS DETECTED BY MAGNETIZATION TRANSFER IMAGING IS LESS PRONOUNCED IN BENIGN THAN IN EARLY RELAPSING MULTIPLE SCLEROSIS. 202
Impact of cognitive impairment on coping strategies in multiple sclerosis. 194
The glycopeptide csf114(glc) detects serum antibodies in multiple sclerosis. 193
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 191
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. 189
Cognitive rehabilitation in children and adolescents with multiple sclerosis. 188
Changes in neuropsychological test performance over the workday in multiple sclerosis. 183
ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis. 181
NEOCORTICAL VOLUME DECREASE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS WITH MILD COGNITIVE IMPAIRMENT. 179
RESPONSE TO INTERFERON-BETA THERAPY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A COMPARISON OF DIFFERENT CLINICAL CRITERIA. 174
Are there protective treatments for cognitive decline in MS? 173
Cognitive impairment in multiple sclerosis. 173
Cognitive and psychosocial features of childhood and juvenile MS. 172
BENIGN MULTIPLE SCLEROSIS: COGNITIVE, PSYCHOLOGICAL AND SOCIAL ASPECTS IN A CLINICAL COHORT. 170
Cognitive changes in multiple sclerosis 166
New natural history of interferon-b treated relapsing multiple sclerosis 165
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta 162
Cognitive dysfunction in multiple sclerosis: current approaches to clinical management. 161
Psychosocial issue in children and adolescents with multiple sclerosis. 160
The contribution of cerebrospinal fluid oligoclonal band sto the early diagnosis of multiple sclerosis 159
Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. 158
Subclinical MS. Follow-up of four cases 157
Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis. 154
Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. 149
Immunomodulatory therapies delay disease progression in multiple sclerosis. 148
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 148
Switching to second-line therapies in interferon- beta treated relapsing-remitting multiple sclerosis patients 145
Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis. 141
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort. 140
The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis. 140
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. 139
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety. 136
Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis. 136
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis 135
Cognitive and psychiatric disorders in multiple sclerosis 134
The harlequin sign: case report and MRI findings 134
Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis 132
Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. 129
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. 129
APOE-{epsilon}4 is not associated with cognitive impairment in relapsing--remitting multiple sclerosis. 126
Clinical management of cognitive impairment in multiple sclerosis: a review of current evidence. 126
Cognitive dysfunction and mood disorders in multiple sclerosis, Blue Book of Practical Neurology: Multiple sclerosis and related CNS inflammatory demylinating disorders, Editors: CF Lucchinetti and R Hohlfeld., in press 120
Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. 120
Multiple sclerosis in Italy: cost-of-illness study. 116
Costi di malattia: revisione degli studi italiani 112
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. 110
Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis. 108
Early prediction of the long-term evolution of multiple sclerosis: the BREMS score 106
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. 104
New natural history of interferon -beta-treated relapsig multiple sclerosis . Reply 103
Disturbi somatoformi 101
Riso e pianto spastico 99
Depressione 92
Correlati clinici 91
Psicosi 87
La sclerosi multipla 84
Storia naturale 79
Disturbi bipolari 79
Profilo del deficit 78
Totale 9.632
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022451 24 64 32 11 9 13 27 20 11 11 133 96
2022/20231.108 114 215 34 89 86 197 160 53 100 3 27 30
2023/2024313 26 39 58 18 22 19 8 53 2 16 39 13
2024/20252.596 78 247 141 349 848 459 14 111 144 59 78 68
2025/20262.452 287 352 170 133 269 100 290 167 150 103 45 386
2026/20279 9 0 0 0 0 0 0 0 0 0 0 0
Totale 9.632